Osteoporosis Drug Development Boosted By New Bone Mineral Density Surrogate Endpoint

 
• By Sue Sutter
  
Hip osteoporosis
The change in hip bone mineral density can support regular approval of new osteoporosis drugs. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from United States